678
Krecmerova, Holy, Masojidkova:
Bis(2-propyl) 3-(2-Chloro-4-pyridinyl)propoxymethanephosphonate (XIII)
Tosylate II (4.59 g, 13 mmol) was added to a solution of alcohol XI (1.5 g, 8.74 mmol) in dimethyl-
formamide (20 ml), the solution was cooled to −20 °C and sodium hydride (60% dispersion; 1.05 g,
26 mmol) was added. The suspension was stirred at −20 °C for 15 min and then the temperature was
increased from −20 °C to −10 °C during 1 h. The reaction mixture was neutralized with acetic acid
(3.5 ml) and the solvent was evaporated. The residue was partitioned between water (200 ml) and
ethyl acetate (300 ml). The organic phase was dried over magnesium sulfate, the solvent was evaporated
and the residue was chromatographed on silica gel (200 ml) in ethyl acetate. The elution afforded
successively: cyclopropyl derivative XIV (RF 0.80), minor amount of unreacted starting alcohol XI
(RF 0.46; 205 mg, 14%), and then phosphonate XIII (RF 0.36). Yield of pure product XIII 800 mg
(26%). For C15H25ClNO4P (349.8) calculated: 51.51% C, 7.20% H, 10.14% Cl, 4.00% N, 8.85% P;
found: 51.23% C, 6.96% H, 9.92% Cl, 3.79% N, 8.56% P. Mass spectrum (FAB, T + G, chloro-
1
form), m/z: 350 (M + H). H NMR spectrum: 1.23 d, 6 H and 1.24 d, 6 H, J(CH3,CH) = 6.1 (CH3);
1.83 m, 2 H (2′-CH2); 2.65 t, 2 H, J(1′,2′) = 7.7 (1′-CH2); 3.49 t, 2 H, J(3′,2′) = 6.3 (3′-CH2); 3.71 d,
2 H, J(P,CH) = 8.1 (PCH2); 4.59 d sept, 2 H, J(CH,CH3) = 6.1, J(P,OCH) = 7.5 (POCH); 7.28 dd,
1 H, J(5,3) = 1.5, J(5,6) = 5.1 (H-5, pyridine); 7.38 d, 1 H, J(3,5) = 1.5 (H-3, pyridine); 8.29 bd, 1 H,
J(6,5) = 5.1 (H-6, pyridine).
2-Chloro-4-cyclopropylpyridine (XIV)
This compound was isolated as the side product in the preparation of phosphonate XIII; yield 0.4 g
1
(30%). H NMR spectrum: 0.85 m, 2 H and 1.08 m, 2 H (2′-CH2); 1.97 tt, 1 H, J(1′,2′-trans) = 4.9,
J(1′,2′-cis) = 8.3 (1′-CH)); 7.09 dd, 1 H, J(5,3) = 1.5, J(5,6) = 5.1 (H-5, pyridine); 7.23 d, 1 H, J(3,5) = 1.5
(H-3, pyridine); 8.19 d, 1 H, J(6,5) = 5.1 (H-6, pyridine).
3-(2-Chloro-4-pyridinyl)propoxymethanephosphonic Acid (XV)
Bromotrimethylsilane (3.3 ml, 25 mmol) was added in an argon atmosphere to a solution of com-
pound XIII (900 mg, 2.6 mmol) in acetonitrile (15 ml) and the solution was stirred in the dark for 20 h.
The reaction was quenched by addition of 1 M triethylammonium hydrogen carbonate to neutrality.
The solvent was evaporated, the residue was codistilled with water (2 × 40 ml), dissolved in water
(4 ml) and applied onto a column of DEAE-Sephadex A-25 (HCO−3 form; 300 ml). The column was
washed with water (600 ml) and then with a gradient of triethylammonium hydrogen carbonate
(0 – 0.5 mol/l; 1 000 ml). The product was eluted at concentration 0.3 – 0.4 mol/l. The product frac-
tions were combined, the solvent was evaporated and the residue was codistilled several times with
water until the decomposition of triethylammonium hydrogen carbonate was complete. The final
purification was performed by chromatography on a reversed phase (C-18); the product was eluted
with a gradient of methanol (0 – 100%). The pure phosphonate XV was eluted with 30% methanol.
Yield 650 mg (82%, about 1/3 of the compound as the bis(triethylammonium) salt), RF 0.20
(2-propanol–25% aqueous ammonia–water 7 : 1 : 2); EAMP 1.25. Mass spectrum (FAB, T + G, methanol),
m/z: 468 (M + H, bis(triethylammonium) salt), 367 (M + H, triethylammonium salt), 266 (M + H,
1
free acid). H NMR spectrum: 1.15 t, 6 H, J(CH3,CH2) = 7.3 (CH3); 1.78 m, 2 H (2′-CH2); 2.65 t, 2 H,
J(1′,2′) = 7.8 (1′-CH2); 2.94 q, 4 H, J(CH2,CH3) = 7.3 (CH2); 3.36 d, 2 H, J(P,CH) = 9.0 (PCH2);
3.41 t, 2 H, J(3′,2′) = 6.3 (3′-CH2); 7.28 dd, 1 H, J(5,3) = 1.5, J(5,6) = 5.1 (H-5, pyridine); 7.37 bs,
1 H (H-3, pyridine); 8.27 d, 1 H, J(6,5) = 5.1 (H-6, pyridine).
Collect. Czech. Chem. Commun. (Vol. 60) (1995)